Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4R5A

A Carbonic Anhydrase IX Mimic in Complex with a Carbohydrate-Based Sulfamate

Summary for 4R5A
Entry DOI10.2210/pdb4r5a/pdb
Related4R59 4R5B
DescriptorCarbonic anhydrase 2, ZINC ION, GLYCEROL, ... (5 entities in total)
Functional Keywordscarbonic anhydrase ix mimic, lyase
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight29791.82
Authors
Mahon, B.P.,McKenna, R. (deposition date: 2014-08-20, release date: 2014-10-15, Last modification date: 2024-10-09)
Primary citationMoeker, J.,Mahon, B.P.,Bornaghi, L.F.,Vullo, D.,Supuran, C.T.,McKenna, R.,Poulsen, S.A.
Structural Insights into Carbonic Anhydrase IX Isoform Specificity of Carbohydrate-Based Sulfamates.
J.Med.Chem., 57:8635-8645, 2014
Cited by
PubMed Abstract: Carbonic anhydrase IX (CA IX) is an extracellular transmembrane homodimeric zinc metalloenzyme that has been validated as a prognostic marker and therapeutic target for several types of aggressive cancers. CA IX shares a close homology with other CA isoforms, making the design of CA IX isoform selective inhibitors challenging. In this paper, we describe the development of a new class of CA IX inhibitors that comprise a sulfamate as the zinc binding group, a variable linker, and a carbohydrate "tail" moiety. Seven compounds inhibited CA IX with low nM Ki values of 1-2 nM and also exhibited permeability profiles to preferentially target the binding of extracellular CA IX over cytosolic CAs. The crystal structures of two of these compounds in complex with a CA IX-mimic (a variant of CA II, with active site residues that mimic CA IX) and one compound in complex with CA II have been determined to 1.7 Å resolution or better and demonstrate a selective mechanism of binding between the hydrophilic and hydrophobic pockets of CA IX versus CA II. These compounds present promising candidates for anti-CA IX drugs and the treatment for several aggressive cancer types.
PubMed: 25254302
DOI: 10.1021/jm5012935
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.64 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon